IHM
CELG

Iguana Healthcare Management’s Celgene Corp CELG Stock Holding History

Iguana Healthcare Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-150,000
Closed -$15.7M – 96
2016
Q3 		$15.7M Buy
+150,000
New +$16.2M 2.8% 11

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's CELG Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 75,000 shares — an estimated $7.83M sold.

Iguana Healthcare Management first reported a position in CELG in Q2 2014 and held it in 15 quarters. The position peaked at $24M in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Iguana Healthcare Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Iguana Healthcare Management sold 75,000 Celgene Corp shares in Q1 2018, an estimated $7.83M.
  • Iguana Healthcare Management first reported a position in Celgene Corp in Q2 2014 and held it in 15 quarters.
  • Iguana Healthcare Management's Celgene Corp position peaked at $24M in Q4 2015.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.